Terms: = Head and neck cancer AND FOXO1, Q12778, FOXO1A, 2308, ENSG00000150907, FKH1, FKHR AND Clinical Outcome
2 results:
1. Genomic Classification and clinical outcome in Rhabdomyosarcoma: A Report From an International Consortium.
Shern JF; Selfe J; Izquierdo E; Patidar R; Chou HC; Song YK; Yohe ME; Sindiri S; Wei J; Wen X; Rudzinski ER; Barkauskas DA; Lo T; Hall D; Linardic CM; Hughes D; Jamal S; Jenney M; Chisholm J; Brown R; Jones K; Hicks B; Angelini P; George S; Chesler L; Hubank M; Kelsey A; Gatz SA; Skapek SX; Hawkins DS; Shipley JM; Khan J
J Clin Oncol; 2021 Sep; 39(26):2859-2871. PubMed ID: 34166060
[TBL] [Abstract] [Full Text] [Related]
2. foxo1 overexpression and loss of pSerine256-foxo1 expression predicts clinical outcome in esophageal adenocarcinomas.
Grupp K; Uzunoglu FG; Melling N; Hofmann B; El Gammal AT; Grotelüschen R; Heumann A; Bellon E; Reeh M; Wolters-Eisfeld G; Ghabdan T; Nentwich M; Bachmann K; Bockhorn M; Bogoevski D; Izbicki JR; Kutup A
Sci Rep; 2018 Nov; 8(1):17370. PubMed ID: 30478420
[TBL] [Abstract] [Full Text] [Related]
